Skip to content

Clinical study of NAFLD syndrome based on gender and disease subtypes

Clinical study of NAFLD syndrome based on gender and disease subtypes

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017321
Enrollment
Unknown
Registered
2018-07-24
Start date
2018-07-24
Completion date
Unknown
Last updated
2018-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nonalcoholic fatty liver disease

Interventions

Case series:Nil

Sponsors

Nanjing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Identified by the diagnostic standard of NAFLD; (2) There was no history of antibiotic application in the last three months; (3) Between 18-80 years of age; (4) Volunteer to participate in the study and sign informed consent.

Exclusion criteria

Exclusion criteria: (1) With serious diseases, such as heart, brain and lung, renal insufficiency and electrolyte disturbance; (2) Diagnosis of severe hepatitis (including acute, subacute and chronic severe hepatitis); (3) women in lactation and pregnancy; (4) patients who are unable to cooperate or be mentally ill.

Design outcomes

Primary

MeasureTime frame
TCM syndrome score;intestinal microbiota;

Secondary

MeasureTime frame
CK-18;

Countries

China

Contacts

Public ContactFang Nanyuan
lionlog@njucm.edu.cn+86 13951945606

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026